Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Blood (2022) 140 (Supplement 1): 6690–6692.

https://doi.org/10.1182/blood-2022-157438

Published: 2022

Journal Articles

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Blood (2021) 137 (11): 1491–1502.

https://doi.org/10.1182/blood.2020007245

Published: 2021

Includes: Supplemental data

Journal Articles

Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials

Blood (2018) 132 (Supplement 1): 4109.

https://doi.org/10.1182/blood-2018-99-116750

Published: 2018

Journal Articles

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Harumi Kato, MD, Naoyuki Tange, MD, Chisako Iriyama, MD PhD, Yuki Kojima, MD, Hirofumi Taji, MD PhD, Tomohiro Kinoshita, MD PhD, Yasushi Yatabe, MD PhD, Shigeo Nakamura, MD PhD, Kazuhito Yamamoto, MDPhD

Blood (2017) 130 (Supplement 1): 4063.

https://doi.org/10.1182/blood.V130.Suppl_1.4063.4063

Published: 2017

Journal Articles

Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA

Akihiro Tomita, MDPhD, Kazuyuki Shimada, MD, Kenichi Yoshida, MD PhD, Yasuhiro Suzuki, MD PhD, Chisako Iriyama, MD PhD, Masashi Sanada, MD PhD, Masaaki Yuge, MD PhD, Yusuke Takagi, MD PhD, Shigeru Kusumoto, MD, Yasufumi Masaki, MD PhD, Takahiko Ito, MD PhD, Yuichiro Inagaki, MD PhD, Akinao Okamoto, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, B.A., Hiroko Tanaka, B.A., Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2017) 130 (Supplement 1): 1452.

https://doi.org/10.1182/blood.V130.Suppl_1.1452.1452

Published: 2017

Journal Articles

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Blood (2016) 128 (22): 3390.

https://doi.org/10.1182/blood.V128.22.3390.3390

Published: 2016

Journal Articles

Emetine Elicits Apoptosis of Intractable B-Cell Lymphoma Cells with MYC Rearrangement through Inhibition of Glycolytic Metabolism

Tomohiro Aoki, MD, Kazuyuki Shimada, MD PhD, Akihiko Sakamoto, PhD, Keiki Sugimoto, PhD, Takanobu Morishita, MD, Yuki Kojima, MD, Satoko Shimada, MD PhD, Seiichi Kato, MD PhD, Chisako Iriyama, MD PhD, Shunsuke Kuno, MD, Yasuhiko Harada, MD, Shigeo Nakamura, MD PhD, Akihiro Tomita, MD PhD, Fumihiko Hayakawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2016) 128 (22): 3019.

https://doi.org/10.1182/blood.V128.22.3019.3019

Published: 2016

Journal Articles

Utilization of Peripheral Blood Cell-Free DNA in Myelodysplastic Syndromes: Clinical and Molecular Characteristics and Utilization for Genetic Analyses Using Conventional and Next-Generation Strategies

Akihiro Tomita, MD PhD, Yasuhiro Suzuki, MD, Fumika Nakamura, Chisako Iriyama, MD PhD, Mizuho Shirahata-Adachi, MD, Kazuyuki Shimada, MD PhD, Akimi Akashi, Yuichi Ishikawa, MDPhD, Norio Kaneda, PhD, Hitoshi Kiyoi, MD PhD

Blood (2015) 126 (23): 4102.

https://doi.org/10.1182/blood.V126.23.4102.4102

Published: 2015

Journal Articles

Genomic Dissection of the Fcγ Receptor Region in the Context of Monoclonal Antibody Therapy

Chantal Hargreaves, PhD, Chisako Iriyama, MD PhD, Matthew JJ Rose-Zerilli, PhD, Charlotte Lee, BSc, Kathleen Potter, PhD, Rosalind Ganderton, Khiyam Hussain, Lee Machado, PhD, Edward Hollox, Sarah E Coupland, MBBS, PhD, Michael Stackpole, Melanie Oates, PhD, Andrew R. Pettitt, PhD MRCPath, Mark Cragg, PhD, Jonathan C Strefford, PhD

Blood (2014) 124 (21): 2996.

https://doi.org/10.1182/blood.V124.21.2996.2996

Published: 2014

Journal Articles

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Yasuhiro Suzuki, MD, Akihiro Tomita, MD PhD, Kenichi Yoshida, MD PhD, Kazuyuki Shimada, MD PhD, Chisako Iriyama, MD PhD, Masashi Sanada, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2014) 124 (21): 1658.

https://doi.org/10.1182/blood.V124.21.1658.1658

Published: 2014

Journal Articles

Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity

Andrew T. Vaughan, Chisako Iriyama, Stephen A. Beers, Claude H. T. Chan, Sean H. Lim, Emily L. Williams, Vallari Shah, Ali Roghanian, Bjorn Frendéus, Martin J. Glennie, Mark S. Cragg

Blood (2014) 123 (5): 669–677.

https://doi.org/10.1182/blood-2013-04-490821

Published: 2014

Includes: Supplemental data

Journal Articles

Usefulness of Peripheral Blood Circulating DNAs As an Alternative to DNA From Bone Marrow Cells to Detect CpG Global Methylation Status and Genetic Mutations in Patients with Myelodysplastic Syndromes

Chisako Iriyama, MD, PhD, Akihiro Tomita, MD, PhD, Hideaki Hoshino, Mizuho Shirahata, MD, Yoko Hibi, PhD, Kiyofumi Yamada, PhD, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 3854.

https://doi.org/10.1182/blood.V120.21.3854.3854

Published: 2012

Journal Articles

Clinical Significance of Genetic Mutations of CD79B , CARD11 , MYD88 , and EZH2 Genes in Diffuse Large B-Cell Lymphoma Patients

Chisako Iriyama, MD, Akihiro Tomita, MD, PhD, Takashi Tokunaga, MD, Keisuke Sugiyama, PharmD, Junji Hiraga, MD, PhD, Tomohiro Kinoshita, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2011) 118 (21): 2633.

https://doi.org/10.1182/blood.V118.21.2633.2633

Published: 2011

Journal Articles

CD20-Negative Phenotypic Change In B-Cell Lymphoma Cells After Using Rituximab: Possibility of a Particular Clinicopathologic Phenomenon Post-Rituximab Extranodal CD20-Negative Lymphoma

Akihiro Tomita, MD, PhD, Takashi Tokunaga, MD, Chisako Iriyama, MD, Kazuyuki Shimada, MD, PhD, Junji Hiraga, MD, PhD, Takumi Sugimoto, MD, PhD, Hitoshi Kiyoi, MD, PhD, Shigeo Nakamura, MD, PhD, Tomohiro Kinoshita, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2010) 116 (21): 2874.

https://doi.org/10.1182/blood.V116.21.2874.2874

Published: 2010

NARROW

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Emetine Elicits Apoptosis of Intractable B-Cell Lymphoma Cells with MYC Rearrangement through Inhibition of Glycolytic Metabolism

Utilization of Peripheral Blood Cell-Free DNA in Myelodysplastic Syndromes: Clinical and Molecular Characteristics and Utilization for Genetic Analyses Using Conventional and Next-Generation Strategies

Genomic Dissection of the Fcγ Receptor Region in the Context of Monoclonal Antibody Therapy

Clinical and Molecular Significance of Peripheral Blood Cell-Free DNA in B-Cell Lymphomas for Detection of Genetic Mutations and Correlation with Disease Status

Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity

Usefulness of Peripheral Blood Circulating DNAs As an Alternative to DNA From Bone Marrow Cells to Detect CpG Global Methylation Status and Genetic Mutations in Patients with Myelodysplastic Syndromes

Clinical Significance of Genetic Mutations of CD79B , CARD11 , MYD88 , and EZH2 Genes in Diffuse Large B-Cell Lymphoma Patients

CD20-Negative Phenotypic Change In B-Cell Lymphoma Cells After Using Rituximab: Possibility of a Particular Clinicopathologic Phenomenon Post-Rituximab Extranodal CD20-Negative Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only